Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals - Takeaways - MDSpire

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

  • By

  • Jiazi Tian

  • Alaleh Azhir

  • Matthew Decaro

  • Ngan Chau

  • Jonas Hügel

  • Michele Morris

  • Jingya Cheng

  • Pedram Fard

  • Ingrid V. Bassett

  • Douglas S. Bell

  • Elmer V. Bernstam

  • Shyam Visweswaran

  • Jeffrey G. Klann

  • Shawn N. Murphy

  • Hossein Estiri

  • May 27, 2026

  • 0 min

Share

  • 1

    Postacute sequelae of SARS-CoV-2 infection (PASC) prevalence is estimated at 43%, contrasting with lower figures from diagnostic coding.

  • 2

    Patients with PASC show increased healthcare utilization, including higher hospitalization rates and specialist consultations.

  • 3

    Longitudinal studies indicate that 45% of COVID-19 survivors have unresolved symptoms at 4 months, with 30% persistent at 24 months.

  • 4

    The P2RC algorithm, an AI system, achieved 80% precision in identifying PASC cases, highlighting distinct endotypes based on organ involvement.

  • 5

    The study utilized EHR data from 58 hospitals across diverse US regions to quantify true PASC prevalence and assess chronic disease patterns.

Original Source(s)

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

  • by Jiazi Tian, Alaleh Azhir, Matthew Decaro, Ngan Chau, Jonas Hügel, Michele Morris, Jingya Cheng, Pedram Fard, Ingrid V. Bassett, Douglas S. Bell, Elmer V. Bernstam, Shyam Visweswaran, Jeffrey G. Klann, Shawn N. Murphy, Hossein Estiri

  • May 27, 2026

Related Content

Human Papillomavirus Vaccine Discourse and Sentiment on Reddit Before and After COVID-19: Mixed Methods Retrospective Cross-Sectional Study

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis